<!DOCTYPE html><html class="" data-reactroot=""><head><meta charSet="utf-8"/><meta name="save" content="history"/><meta http-equiv="X-UA-Compatible" content="IE=edge"/><meta name="baidu-site-verification" content="VWGb6TyYx8"/><meta content="蛋白降解靶向嵌合体 - 搜狗科学百科" name="keywords"/><meta content="搜狗科学百科是一部有着平等、协作、分享、自由理念的网络科学全书，为每一个互联网用户创造一个涵盖所有领域知识、服务的中文知识性平台。" name="description"/><meta http-equiv="x-dns-prefetch-control" content="on"/><meta name="server" baike="235" ip="210" env="online"/><link rel="dns-prefetch" href="//cache.soso.com"/><link rel="dns-prefetch" href="//hhy.sogoucdn.com"/><link rel="dns-prefetch" href="//pic.baike.soso.com"/><link rel="dns-prefetch" href="//ugc.qpic.cn"/><link rel="dns-prefetch" href="//xui.ptlogin2.qq.com"/><link rel="dns-prefetch" href="//q1.qlogo.cn"/><link rel="dns-prefetch" href="//q2.qlogo.cn"/><link rel="dns-prefetch" href="//q3.qlogo.cn"/><link rel="dns-prefetch" href="//q4.qlogo.cn"/><link rel="dns-prefetch" href="//q.qlogo.cn"/><link rel="dns-prefetch" href="//img01.sogoucdn.com"/><link rel="dns-prefetch" href="//img02.sogoucdn.com"/><link rel="dns-prefetch" href="//img03.sogoucdn.com"/><link rel="dns-prefetch" href="//img04.sogoucdn.com"/><link rel="Shortcut Icon" href="//www.sogou.com/images/logo/new/favicon.ico?v=4"/><link rel="Bookmark" href="//www.sogou.com/images/logo/new/favicon.ico?v=4"/><link href="//hhy.sogoucdn.com/deploy/ued/new_baike/pc/dist/css/base_b849887.css" rel="stylesheet"/><link href="//hhy.sogoucdn.com/deploy/ued/new_baike/pc/dist/css/detail/detail_378aed5.css" rel="stylesheet"/><link href="//hhy.sogoucdn.com/deploy/ued/new_baike/pc/dist/css/inviteAudit/inviteAudit_7894507.css" rel="stylesheet"/><link rel="stylesheet" href="//hhy.sogoucdn.com/js/lib/highlight/highlight.min.css"/><title>蛋白降解靶向嵌合体 - 搜狗科学百科</title></head><body><script>window._gtag=window._gtag||{};window._gtag.shouldGrayed = false;if ('2b13bd0574a540a19aed47f19a137480') window._gtag.traceId = '2b13bd0574a540a19aed47f19a137480';if ({"illegality":true}) window.userInfo = {"illegality":true};</script><div class="topnavbox"><ul class="topnav"><li><a href="//www.sogou.com/web?query=">网页</a></li><li><a href="//weixin.sogou.com/weixin?p=75351201">微信</a></li><li><a href="//zhihu.sogou.com/zhihu?p=75351218">知乎</a></li><li><a href="//pic.sogou.com/pics?query=">图片</a></li><li><a href="//v.sogou.com/v?query=">视频</a></li><li><a href="//mingyi.sogou.com/">医疗</a></li><li class="cur"><strong>科学</strong></li><li><a href="//hanyu.sogou.com/">汉语</a></li><li><a href="//wenwen.sogou.com/">问问</a></li><li><a href="//www.sogou.com/docs/more.htm">更多<span class="topraquo">»</span></a></li></ul></div><div id="header"><div class="header-wrap"><a class="header-logo" href="/kexue"></a><div class="header-search"><div class="querybox" id="suggBox"></div></div><div class="header-rgt"><span class="btn-header-rgt btn-edit" id="editLemma">创建</span><div class="header-user no-login"></div></div></div></div><div class="fixed-placeholder" style="visibility:none"></div><div id="container" class=""><div class="content lemma-level1"><div class="detail-title" id="abstract-title"><h1>蛋白降解靶向嵌合体</h1><a href="#!" class="detail-edit">编辑</a></div><div class="section_content" data-id="82671465077486089"><div class="text_img ed_imgfloat_right"><a class="ed_image_link" data-src="https://img02.sogoucdn.com/app/a/200698/1269_557_20210225145135-1320567354.png" data-bigsrc="https://img02.sogoucdn.com/app/a/200698/1269_557_20210225145135-1320567354.png?width=231&amp;height=174&amp;titlename=PROTAC%E8%AF%B1%E5%AF%BC%E7%9A%84%E8%9B%8B%E7%99%BD%E8%B4%A8%E9%99%8D%E8%A7%A3%E6%9C%BA%E7%90%86%E5%9B%BE%E7%A4%BA%EF%BC%8CE3%E8%BF%9E%E6%8E%A5%E9%85%B6%E8%A2%ABPROTAC%E5%8B%9F%E9%9B%86%EF%BC%8C%E9%99%8D%E8%A7%A3%E9%9D%B6%E8%9B%8B%E7%99%BD%E3%80%82%EF%BC%88%E5%9B%BE%E7%89%87%E5%87%BA%E5%A4%84%EF%BC%9ACorson%EF%BC%8C2008%E5%B9%B4%EF%BC%89&amp;w=1269&amp;h=557" title="点击查看大图" data-w="1269" data-h="557" style="background-image:url(https://img02.sogoucdn.com/app/a/200698/1269_557_20210225145135-1320567354.png)" href="#!"></a><div class="text_img_title">PROTAC诱导的蛋白质降解机理图示，E3连接酶被PROTAC募集，降解靶蛋白。（图片出处：Corson，2008年）</div></div><div><p>蛋白降解靶向嵌合体（英文：<b>pro</b>teolysis<b> t</b>argeting <b>c</b>himera 缩写：PROTAC）是一种异双功能小分子，由三部分组成：热门靶向蛋白高度亲和力小分子，E3连接酶高度亲和力的小分子以及连接两者的链接子。E3连接酶与靶蛋白的结合导致蛋白酶体的泛素化和靶蛋白的后续降解。</p></div></div><div id="catalog"></div><div id="paragraphs"></div><div id="references"></div><div id="recommendReferences"></div><div class="read-num">阅读 <!-- -->6.2<!-- -->w</div></div><div class="right-side" id="rightSide"></div></div><div class="footer-box"><div id="footer"><div class="footer-logo-wrap"><div class="footer-logo"></div><div class="footer-logo-text">知识·传播·科普</div></div><div class="footer-info">本网站内容采用<a target="_blank" href="https://creativecommons.org/licenses/by-sa/3.0/deed.zh?tdsourcetag=s_pctim_aiomsg">CC-BY-SA 3.0</a>授权</div><div class="footer-btn-wrap"><a target="_blank" href="https://baike.sogou.com/help/#user_protocol">用户协议</a><a target="_blank" href="http://www.sogou.com/docs/terms.htm?v=1">免责声明</a><a target="_blank" href="http://corp.sogou.com/private.html">隐私政策</a><a target="_blank" href="https://baike.sogou.com/kexue/intro.htm">关于我们</a></div></div></div><script>window.lemmaInfo ={"lemmaId":"78751394722558220","versionId":"82803858602013191","title":"蛋白降解靶向嵌合体","subtitle":"","abstracts":{"paragraphId":"82671465077486089","title":"摘要","versionId":"82671465077486083","lemmaId":78751394722558220,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":77609388,"name":"文鶴山下，費翔","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1616572033,"comment":null,"dependVersionId":0,"contentType":2,"content":"<p>蛋白降解靶向嵌合体（英文：<b>pro</b>teolysis<b> t</b>argeting <b>c</b>himera 缩写：PROTAC）是一种异双功能小分子，由三部分组成：热门靶向蛋白高度亲和力小分子，E3连接酶高度亲和力的小分子以及连接两者的链接子。E3连接酶与靶蛋白的结合导致蛋白酶体的泛素化和靶蛋白的后续降解。</p>","pics":[{"originalUrl":"https://img02.sogoucdn.com/app/a/200698/1269_557_20210225145135-1320567354.png?width=231&height=174&titlename=PROTAC%E8%AF%B1%E5%AF%BC%E7%9A%84%E8%9B%8B%E7%99%BD%E8%B4%A8%E9%99%8D%E8%A7%A3%E6%9C%BA%E7%90%86%E5%9B%BE%E7%A4%BA%EF%BC%8CE3%E8%BF%9E%E6%8E%A5%E9%85%B6%E8%A2%ABPROTAC%E5%8B%9F%E9%9B%86%EF%BC%8C%E9%99%8D%E8%A7%A3%E9%9D%B6%E8%9B%8B%E7%99%BD%E3%80%82%EF%BC%88%E5%9B%BE%E7%89%87%E5%87%BA%E5%A4%84%EF%BC%9ACorson%EF%BC%8C2008%E5%B9%B4%EF%BC%89&w=1269&h=557","url":"https://img02.sogoucdn.com/app/a/200698/1269_557_20210225145135-1320567354.png","rw":1269,"rh":557,"title":"PROTAC诱导的蛋白质降解机理图示，E3连接酶被PROTAC募集，降解靶蛋白。（图片出处：Corson，2008年）","alt":null,"width":231,"height":174}],"card":null,"references":[],"versionCount":0},"card":{"paragraphId":"82671465077486090","title":"基本信息","versionId":"82803858602013192","lemmaId":78751394722558220,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":77609388,"name":"文鶴山下，費翔","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1616650945,"comment":null,"dependVersionId":0,"contentType":3,"content":"","pics":null,"card":{"cardItems":[{"key":"中文名","value":"蛋白降解靶向嵌合体"},{"key":"英文","value":"proteolysis targeting chimera"},{"key":"特征","value":"PROTAC是具有连接子和双头分子的小分子，能够通过诱导选择性细胞内蛋白水解作用降解靶蛋白。"},{"key":"提出者","value":"克雷格·克鲁斯（Craig Crews）雷蒙德·约瑟夫·德沙伊斯（Raymond Joseph Deshaies <sup><a href=\"#quote_1\" class=\"kx_ref\">[1]</a></sup>"},{"key":"数据库","value":"侯廷军教授课题组网站整理了目前所公布的PROTAC数据库http://cadd.zju.edu.cn/protacdb/about"},{"key":"PROTAC初创企业","value":"美国Arvinas， Kymera，C4 Therapeutics，Vividion，Nurix韩国Ubix Therapeutics 凌科药业，成都分迪科技，苏州开拓药业，五元生物 <sup><a href=\"#quote_2\" class=\"kx_ref\">[2]</a></sup>"},{"key":"进入临床药物","value":"ARV-110用于治疗转移性去势抵抗性前列腺癌患者和ARV-471用于治疗ER+ / HER2-局部晚期或转移性乳腺癌"}]},"references":[],"versionCount":0},"categories":[{"id":446,"name":"化学生物学","parents":[[{"id":3,"name":"化学","parents":null}]]}],"creator":{"uid":77609388,"name":"文鶴山下，費翔","pic":"https://cache.soso.com/thirdwx_qlogo/mmopen/vi_32/2Vx3Ds3Biblnojzo4u8zYdv3e5BzAiaZocz5NeunSibwa3zHD3LnM7jw41BuCsiaibXN99sKKbklchadNnCO4BDxNOg/132","introduction":null,"educations":[{"schoolName":"嘉泉大学","major":"","degree":"博士","universityId":127,"universityLogo":null,"majorLevel1":null,"majorLevel2":null,"majorLevel3":null,"majorLevel1Id":0,"majorLevel2Id":0,"majorLevel3Id":0,"state":null,"lab":null,"researchField":null}],"jobs":null,"works":null,"educationBrief":"嘉泉大学","jobBrief":"","role":0,"roleName":null,"title":"嘉泉大学 · 博士","professionalTitle":"嘉泉大学药学院研究员","phoneNo":null,"editable":true,"partnerId":226,"partnerIdCreateTime":1595845083,"partnerIdPoped":true},"createTime":1614235489,"editor":{"uid":77609388,"name":"文鶴山下，費翔","pic":"https://cache.soso.com/thirdwx_qlogo/mmopen/vi_32/2Vx3Ds3Biblnojzo4u8zYdv3e5BzAiaZocz5NeunSibwa3zHD3LnM7jw41BuCsiaibXN99sKKbklchadNnCO4BDxNOg/132","introduction":null,"educations":[{"schoolName":"嘉泉大学","major":"","degree":"博士","universityId":127,"universityLogo":null,"majorLevel1":null,"majorLevel2":null,"majorLevel3":null,"majorLevel1Id":0,"majorLevel2Id":0,"majorLevel3Id":0,"state":null,"lab":null,"researchField":null}],"jobs":null,"works":null,"educationBrief":"嘉泉大学","jobBrief":"","role":0,"roleName":null,"title":"嘉泉大学 · 博士","professionalTitle":"嘉泉大学药学院研究员","phoneNo":null,"editable":true,"partnerId":226,"partnerIdCreateTime":1595845083,"partnerIdPoped":true},"editTime":1616650945,"state":1,"versionCount":2,"upNum":74,"downNum":0,"pics":[{"originalUrl":"https://img02.sogoucdn.com/app/a/200698/1269_557_20210225145135-1320567354.png?width=231&height=174&titlename=PROTAC%E8%AF%B1%E5%AF%BC%E7%9A%84%E8%9B%8B%E7%99%BD%E8%B4%A8%E9%99%8D%E8%A7%A3%E6%9C%BA%E7%90%86%E5%9B%BE%E7%A4%BA%EF%BC%8CE3%E8%BF%9E%E6%8E%A5%E9%85%B6%E8%A2%ABPROTAC%E5%8B%9F%E9%9B%86%EF%BC%8C%E9%99%8D%E8%A7%A3%E9%9D%B6%E8%9B%8B%E7%99%BD%E3%80%82%EF%BC%88%E5%9B%BE%E7%89%87%E5%87%BA%E5%A4%84%EF%BC%9ACorson%EF%BC%8C2008%E5%B9%B4%EF%BC%89&w=1269&h=557","url":"https://img02.sogoucdn.com/app/a/200698/1269_557_20210225145135-1320567354.png","rw":1269,"rh":557,"title":"PROTAC诱导的蛋白质降解机理图示，E3连接酶被PROTAC募集，降解靶蛋白。（图片出处：Corson，2008年）","alt":null,"width":231,"height":174},{"originalUrl":"https://img02.sogoucdn.com/app/a/200698/1269_557_20210225154156-1014230701.png?w=1269&h=557&titlename=PROTAC%E7%A4%BA%E6%84%8F%E5%9B%BE","url":"https://img02.sogoucdn.com/app/a/200698/1269_557_20210225154156-1014230701.png","rw":1269,"rh":557,"title":"PROTAC示意图","alt":null,"width":0,"height":0},{"originalUrl":"https://img02.sogoucdn.com/app/a/200698/1842_786_20210225161104-2144076278.png?w=1842&h=786&titlename=PROTACs%E6%97%B6%E9%97%B4%E7%BA%BF%E6%95%B4%E7%90%86%EF%BC%88%E5%87%BA%E5%A4%84%EF%BC%9A%E8%80%B6%E9%B2%81%E5%A4%A7%E5%AD%A6%20Crews%E6%95%99%E6%8E%88%E5%AE%9E%E9%AA%8C%E5%AE%A4%EF%BC%89","url":"https://img02.sogoucdn.com/app/a/200698/1842_786_20210225161104-2144076278.png","rw":1842,"rh":786,"title":"PROTACs时间线整理（出处：耶鲁大学 Crews教授实验室）","alt":null,"width":0,"height":0},{"originalUrl":"https://img03.sogoucdn.com/app/a/200698/726_266_20210225161629-639628391.png?w=726&h=266&titlename=PROTAC%E4%B8%89%E9%83%A8%E5%88%86%E7%9A%84%E5%A4%9A%E7%A7%8D%E7%BB%84%E5%90%88","url":"https://img03.sogoucdn.com/app/a/200698/726_266_20210225161629-639628391.png","rw":726,"rh":266,"title":"PROTAC三部分的多种组合","alt":null,"width":0,"height":0},{"originalUrl":"https://img03.sogoucdn.com/app/a/200698/1200_642_20210225162356-136826901.png?w=1200&h=642&titlename=PROTAC%E5%88%86%E5%AD%90%E4%BB%8B%E5%AF%BC%E9%9D%B6%E8%9B%8B%E7%99%BD%E9%99%8D%E8%A7%A3%E5%B7%A5%E4%BD%9C%E6%B5%81%E7%A8%8B%E5%9B%BE","url":"https://img03.sogoucdn.com/app/a/200698/1200_642_20210225162356-136826901.png","rw":1200,"rh":642,"title":"PROTAC分子介导靶蛋白降解工作流程图","alt":null,"width":0,"height":0}],"catalogs":[{"level":1,"title":"1.概论","paragraphId":"82671465094263303","subCatalogs":null},{"level":1,"title":"2.PROTAC特点","paragraphId":"82671465094263304","subCatalogs":[{"level":2,"title":"PROTAC优势","paragraphId":"82671465094263304","subCatalogs":null},{"level":2,"title":"PROTAC挑战","paragraphId":"82671465094263304","subCatalogs":null},{"level":2,"title":"PROTAC和其他类型药物特点比较","paragraphId":"82671465094263304","subCatalogs":null}]},{"level":1,"title":"3. 发展历程","paragraphId":"82671465077486092","subCatalogs":null},{"level":1,"title":"4. PROTAC 设计与合成","paragraphId":"82671465077486091","subCatalogs":[{"level":2,"title":"目标蛋白的配体设计","paragraphId":"82671465077486091","subCatalogs":null},{"level":2,"title":"E3连接酶的配体筛选","paragraphId":"82671465077486091","subCatalogs":null},{"level":2,"title":"链接子设计和优化","paragraphId":"82671465077486091","subCatalogs":null},{"level":2,"title":"PROTAC结构修改","paragraphId":"82671465077486091","subCatalogs":null},{"level":2,"title":"PROTAC工作流程图","paragraphId":"82671465077486091","subCatalogs":null},{"level":2,"title":"<br>","paragraphId":"82671465077486091","subCatalogs":null}]},{"level":1,"title":"参考文献","paragraphId":"-1","subCatalogs":null},{"level":1,"title":"推荐文献","paragraphId":"82803858618790415","subCatalogs":null}],"paragraphs":[{"paragraphId":"82671465094263303","title":"1.概论","versionId":"82803858602013193","lemmaId":78751394722558220,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":77609388,"name":"文鶴山下，費翔","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1616650945,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>与直接抑制蛋白质活性的传统药物相比，PROTAC通过利用蛋白酶体介导的蛋白水解作用，使我们体内的蛋白质降解系统参与到消灭靶向蛋白的过程中来，以选择性降解致病蛋白，从而治疗癌症或其他难以治疗的疾病。PROTAC是一种双功能小分子，由一个连接子和两个弹头组成-一个与靶蛋白结合，另一个吸收E3连接酶（见图1）。通过这种双功能特性，致病蛋白可以被蛋白酶体泛素化和降解，从而身体恢复正常。作为一种新颖的药物设计思路，它有可能提供超越现有方法的治疗措施。因为PROTAC只需要以高选择性结合其靶标即可（而不是抑制靶蛋白的酶促活性），因此目前有许多已验证过活性和安全性的小分子抑制剂改造为下一代PROTAC降解剂。<sup><a href=\"#quote_3\" class=\"kx_ref\">[3]</a></sup><br></p><p><img class=\"ed_imgfloat_embedmiddle\" width=\"480\" titlename=\"PROTAC示意图\" bigsrc=\"https://img02.sogoucdn.com/app/a/200698/1269_557_20210225154156-1014230701.png\" data-align=\"embedmiddle\" data-src=\"https://img02.sogoucdn.com/app/a/200698/1269_557_20210225154156-1014230701.png\"></p>","pics":[{"originalUrl":"https://img02.sogoucdn.com/app/a/200698/1269_557_20210225154156-1014230701.png?w=1269&h=557&titlename=PROTAC%E7%A4%BA%E6%84%8F%E5%9B%BE","url":"https://img02.sogoucdn.com/app/a/200698/1269_557_20210225154156-1014230701.png","rw":1269,"rh":557,"title":"PROTAC示意图","alt":null,"width":0,"height":0}],"card":null,"references":[],"versionCount":0},{"paragraphId":"82671465094263304","title":"2.PROTAC特点","versionId":"82803858602013194","lemmaId":78751394722558220,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":77609388,"name":"文鶴山下，費翔","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1616650945,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p><h3>PROTAC优势</h3></p><p>\n <ul>\n  <li><p>克服肿瘤耐药性<br></p></li>\n  <li><p>延长作用时间</p></li>\n  <li><p>降解致病蛋白而不是抑制它们<br></p></li>\n  <li><p>低剂量</p></li>\n  <li><p>减少毒性</p></li>\n </ul></p><p><h3>PROTAC挑战</h3></p><p>\n <ul>\n  <li><p>E3连接酶与靶蛋白的配对组合仍基于传统经验，效率低，不利于E3连接酶配体的开发和利用。<br></p></li>\n  <li><p>配体小分子不易寻找</p></li>\n  <li><p>降解水平的不确定性</p></li>\n  <li><p>耐药性的产生和克服方法&nbsp;</p></li>\n </ul></p><p><h3>PROTAC和其他类型药物特点比较</h3></p><p>\n <table>\n  <tbody>\n   <tr>\n    <td width=\"132\">药物特性</td>\n    <td width=\"132\">小分子</td>\n    <td width=\"132\">单抗</td>\n    <td width=\"132\">siRNA</td>\n    <td width=\"132\">PROTAC</td>\n   </tr>\n   <tr>\n    <td width=\"132\">不需要活性位点</td>\n    <td width=\"132\">需要</td>\n    <td width=\"132\">需要</td>\n    <td width=\"132\">不需要</td>\n    <td width=\"132\">不需要</td>\n   </tr>\n   <tr>\n    <td width=\"132\">彻底消灭蛋白</td>\n    <td width=\"132\">不能</td>\n    <td width=\"132\">不行</td>\n    <td width=\"132\">行</td>\n    <td width=\"132\">行</td>\n   </tr>\n   <tr>\n    <td width=\"132\">靶向支架蛋白</td>\n    <td width=\"132\">不能</td>\n    <td width=\"132\">能</td>\n    <td width=\"132\">行</td>\n    <td width=\"132\">行</td>\n   </tr>\n   <tr>\n    <td width=\"132\">开发难易度</td>\n    <td width=\"132\">难</td>\n    <td width=\"132\">易</td>\n    <td width=\"132\">易</td>\n    <td width=\"132\">易</td>\n   </tr>\n   <tr>\n    <td width=\"132\">组织穿透性</td>\n    <td width=\"132\">能</td>\n    <td width=\"132\">能</td>\n    <td width=\"132\">不能</td>\n    <td width=\"132\">行</td>\n   </tr>\n   <tr>\n    <td width=\"132\">系统给药</td>\n    <td width=\"132\">可行</td>\n    <td width=\"132\">可行</td>\n    <td width=\"132\">不行</td>\n    <td width=\"132\">行</td>\n   </tr>\n   <tr>\n    <td width=\"132\">给药途径</td>\n    <td width=\"132\">PO/IV/SC</td>\n    <td width=\"132\">IV/SC</td>\n    <td width=\"132\">IV/SC</td>\n    <td width=\"132\">PO/IV/SC</td>\n   </tr>\n  </tbody>\n </table></p>","pics":null,"card":null,"references":[],"versionCount":0},{"paragraphId":"82671465077486092","title":"3. 发展历程","versionId":"82671465077486087","lemmaId":78751394722558220,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":77609388,"name":"文鶴山下，費翔","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1616572033,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p><img class=\"kx_img ed_imgfloat_right\" width=\"227\" height=\"174\" titlename=\"PROTACs时间线整理（出处：耶鲁大学 Crews教授实验室）\" bigsrc=\"https://img02.sogoucdn.com/app/a/200698/1842_786_20210225161104-2144076278.png\" data-src=\"https://img02.sogoucdn.com/app/a/200698/1842_786_20210225161104-2144076278.png\">PROTAC技术发展历程有20年之久，Proteinix公司的研究人员1999年递交了基于泛素机制使用小分子化合物降解特定蛋白的专利申请。两年之后，Craig Crews和 Raymond Deshaies博士基于多肽的化合物设计了系列的双功能小分子诱导甲硫氨酰氨肽酶2（MetAP-2）降解，并正式提出PROTAC概念。但由于这些基于大而笨重的肽而起连接作用的化合物很难以进入细胞，第一代PROTACs宣告失败。直到2008年，Crews团队基于E3的泛素蛋白连接酶MDM2设计出了可用于降解雄激素受体(AR)的第二代PROTACs。2015年Crews团队则基于新型E3泛素连接酶VHL和CRBN配体设计出使多种蛋白的水平降低超过90%的新一代PROTACs。也是这一年，诺华的研发负责人James Bradner在《Science》上发表新一代基于沙利度胺类似物的PROTAC分子，从而引爆了整个领域。Crews在2013年则已成立了全球首家以PROTAC技术进行药物研发的公司Arvinas。</p><p>令人对此项技术看好的是，该公司开发的全球首个PROTAC药物ARV-110，拟用于治疗去势抵抗性前列腺癌，已经进入临床I期研究阶段，临床I期的初始数据表明ARV-110具有良好的口服利用度和良好的安全性和耐受性<sup><a href=\"#quote_4\" class=\"kx_ref\">[4]</a></sup>。</p><p>到目前为止，蛋白降解剂的研究主要集中在肿瘤领域，并在神经退行性疾病、炎症/免疫学领域有所发现。<br></p>","pics":[{"originalUrl":"https://img02.sogoucdn.com/app/a/200698/1842_786_20210225161104-2144076278.png?w=1842&h=786&titlename=PROTACs%E6%97%B6%E9%97%B4%E7%BA%BF%E6%95%B4%E7%90%86%EF%BC%88%E5%87%BA%E5%A4%84%EF%BC%9A%E8%80%B6%E9%B2%81%E5%A4%A7%E5%AD%A6%20Crews%E6%95%99%E6%8E%88%E5%AE%9E%E9%AA%8C%E5%AE%A4%EF%BC%89","url":"https://img02.sogoucdn.com/app/a/200698/1842_786_20210225161104-2144076278.png","rw":1842,"rh":786,"title":"PROTACs时间线整理（出处：耶鲁大学 Crews教授实验室）","alt":null,"width":0,"height":0}],"card":null,"references":[],"versionCount":0},{"paragraphId":"82671465077486091","title":"4. PROTAC 设计与合成","versionId":"82803858602013195","lemmaId":78751394722558220,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":77609388,"name":"文鶴山下，費翔","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1616650945,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p></p><h3>目标蛋白的配体设计</h3><p></p><p>用泛素化标记靶蛋白是被PROTAC分子降解之前的关键事件。配体设计可以参考现有的相关把蛋白小分子抑制剂。</p><p></p><h3>E3连接酶的配体筛选</h3><p></p><p>可以募集E3连接酶来标记目标蛋白，以通过蛋白酶体进行泛素化和降解。</p><p></p><h3>链接子设计和优化</h3><p></p><p>如图所示<sup><a href=\"#quote_5\" class=\"kx_ref\">[5]</a></sup>，PROTAC接头连接两个头：用于E3泛素连接酶识别的小肽或分子，以及用于靶蛋白识别的配体。使用多种类型的链接子可以优化PROTAC的长度和位置，以使靶蛋白和E3连接酶之间达到最大相互作用，从而实现靶蛋白的有效泛素化及其最终降解。</p><p><img class=\"kx_img ed_imgfloat_right\" width=\"227\" height=\"174\" titlename=\"PROTAC三部分的多种组合\" bigsrc=\"https://img03.sogoucdn.com/app/a/200698/726_266_20210225161629-639628391.png\" data-src=\"https://img03.sogoucdn.com/app/a/200698/726_266_20210225161629-639628391.png\"></p><p></p><h3>PROTAC结构修改</h3><p></p><p>PROTAC分子的细胞渗透性和降解选择性程度可以通过可变接头E3连接酶部分组合与特定目标蛋白配体的结构修饰或“混合和匹配”来优化。</p><p></p><h3>PROTAC工作流程图</h3><p></p><p><img class=\"kx_img ed_imgfloat_right currentPic\" width=\"227\" height=\"174\" titlename=\"PROTAC分子介导靶蛋白降解工作流程图\" bigsrc=\"https://img03.sogoucdn.com/app/a/200698/1200_642_20210225162356-136826901.png\" data-src=\"https://img03.sogoucdn.com/app/a/200698/1200_642_20210225162356-136826901.png\"></p><p>第一步：如何成功构建PROTAC分子</p><p>第二步：PROTAC分子能否成功穿透并进入细胞；</p><p>第三步：一旦进入细胞，靶蛋白-PROTAC分子- E3连接酶的三元复合物能否形成；</p><p>第四步：能否形成活化的E3复合体；</p><p>第五步：靶蛋白能否被泛素化；</p><p>第六步：泛素化的靶蛋白能否被蛋白酶体识别并结合；</p><p>第七步：靶蛋白是否发生降解。</p><p></p><h3><br></h3><p></p>","pics":[{"originalUrl":"https://img03.sogoucdn.com/app/a/200698/726_266_20210225161629-639628391.png?w=726&h=266&titlename=PROTAC%E4%B8%89%E9%83%A8%E5%88%86%E7%9A%84%E5%A4%9A%E7%A7%8D%E7%BB%84%E5%90%88","url":"https://img03.sogoucdn.com/app/a/200698/726_266_20210225161629-639628391.png","rw":726,"rh":266,"title":"PROTAC三部分的多种组合","alt":null,"width":0,"height":0},{"originalUrl":"https://img03.sogoucdn.com/app/a/200698/1200_642_20210225162356-136826901.png?w=1200&h=642&titlename=PROTAC%E5%88%86%E5%AD%90%E4%BB%8B%E5%AF%BC%E9%9D%B6%E8%9B%8B%E7%99%BD%E9%99%8D%E8%A7%A3%E5%B7%A5%E4%BD%9C%E6%B5%81%E7%A8%8B%E5%9B%BE","url":"https://img03.sogoucdn.com/app/a/200698/1200_642_20210225162356-136826901.png","rw":1200,"rh":642,"title":"PROTAC分子介导靶蛋白降解工作流程图","alt":null,"width":0,"height":0}],"card":null,"references":[],"versionCount":0}],"references":[{"id":1,"type":"journal","title":"Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation","site":"","url":"","journalName":"PNAS","author":"Sakamoto KM, Kim KB, Kumagai A, Mercurio F, Crews CM, Deshaies RJ","press":"","publishYear":"","publishTime":"2001","publishPlace":"","page":"","volume":"","quoteTime":"2021-02-25","quoted":false},{"id":2,"type":"web","title":"全球首个PROTAC药物ARV-110最新进展及管线布局浅谈","site":"新浪医药新闻","url":"https://med.sina.com/article_detail_103_2_85518.html","journalName":null,"author":"","press":"","publishYear":"","publishTime":"2020-07-02","publishPlace":"","page":"","volume":"","quoteTime":"2021-02-25","quoted":false},{"id":3,"type":"journal","title":"Next-Generation Drugs and Probes for Chromatin Biology: From Targeted Protein Degradation to Phase Separation","site":"","url":"http://www.mdpi.com/1420-3049/23/8/1958","journalName":"Molecules","author":"Katerina Cermakova,H. Hodges","press":"","publishYear":"","publishTime":"2018-08-06","publishPlace":"","page":"1958","volume":"23","quoteTime":"2021-02-25","quoted":false},{"id":4,"type":"journal","title":"Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery","site":"","url":"https://linkinghub.elsevier.com/retrieve/pii/S0092867419313169","journalName":"Cell","author":"George M. Burslem,Craig M. Crews","press":"","publishYear":"","publishTime":"2020-04","publishPlace":"","page":"102-114","volume":"181","quoteTime":"2021-02-25","quoted":false},{"id":5,"type":"journal","title":"Design and Applications of Bifunctional Small Molecules: Why Two Heads Are Better Than One","site":"","url":"https://pubs.acs.org/doi/10.1021/cb8001792","journalName":"ACS Chemical Biology","author":"Timothy W. Corson,Nicholas Aberle,Craig M. Crews","press":"","publishYear":"","publishTime":"2008-11-21","publishPlace":"","page":"677-692","volume":"3","quoteTime":"2021-02-25","quoted":false}],"recommendReferences":{"paragraphId":"82803858618790415","title":"推荐文献","versionId":"82803858602013196","lemmaId":78751394722558220,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":77609388,"name":"文鶴山下，費翔","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1616650945,"comment":null,"dependVersionId":0,"contentType":4,"content":"","pics":null,"card":null,"references":[{"id":1,"type":"web","title":"2020-2021【Dana-Farber癌症研究所】靶向蛋白降解研讨会 ","site":"bilibili","url":"https://www.bilibili.com/video/BV1Yy4y1a7De?p=1","journalName":null,"author":"","press":"","publishYear":"","publishTime":"2021-03-24","publishPlace":"","page":"","volume":"","quoteTime":"2021-03-25","quoted":false}],"versionCount":0},"auditState":2,"lemmaLevel":1,"origin":0,"originEnTitle":null,"originZhTitle":null,"pv":62077,"auditType":1,"synonyms":null,"showEditTime":"2021.03.25 13:42","auditors":[{"uid":220012,"name":"思明","pic":"https://cache.soso.com/qlogo/g?b=oidb&k=cquZ3H4l5tJt7m8ZWXibvpg&s=100&t=1557929484","introduction":"","educations":null,"jobs":null,"works":null,"educationBrief":"","jobBrief":"","role":0,"roleName":null,"title":"","professionalTitle":"","phoneNo":null,"editable":true,"partnerId":201,"partnerIdCreateTime":1595845027,"partnerIdPoped":true},{"uid":78705407,"name":"陈清文","pic":"https://img02.sogoucdn.com/app/a/200698/698_698_844813_20200806005338-457831853.png","introduction":"","educations":[{"schoolName":"大阪大学","major":"","degree":"博士","universityId":115,"universityLogo":"","majorLevel1":null,"majorLevel2":null,"majorLevel3":null,"majorLevel1Id":0,"majorLevel2Id":0,"majorLevel3Id":0,"state":"在读","lab":"","researchField":""}],"jobs":null,"works":null,"educationBrief":"大阪大学","jobBrief":"","role":0,"roleName":null,"title":"大阪大学 · 博士","professionalTitle":null,"phoneNo":null,"editable":true,"partnerId":18,"partnerIdCreateTime":1594286498,"partnerIdPoped":true}],"hasZhishiNav":false,"auditInfos":{"0":[{"versionId":"0","auditTime":1616899457,"auditorId":78705407,"auditUser":{"uid":78705407,"name":"陈清文","pic":"https://img02.sogoucdn.com/app/a/200698/698_698_844813_20200806005338-457831853.png","introduction":"","educations":[{"schoolName":"大阪大学","major":"","degree":"博士","universityId":115,"universityLogo":"","majorLevel1":null,"majorLevel2":null,"majorLevel3":null,"majorLevel1Id":0,"majorLevel2Id":0,"majorLevel3Id":0,"state":"在读","lab":"","researchField":""}],"jobs":null,"works":null,"educationBrief":"大阪大学","jobBrief":"","role":0,"roleName":null,"title":"大阪大学 · 博士","professionalTitle":null,"phoneNo":null,"editable":true,"partnerId":18,"partnerIdCreateTime":1594286498,"partnerIdPoped":true},"auditReason":null,"auditSuggest":"本词条选题较新，对该领域发展方向有很好的普及和推动作用。\n详细介绍了PROTAC的基本构成以及优势和挑战，为词条生长搭建了很好的基本框架。\n大体上正确，基于本词条选题和介绍的框架，评为优秀，希望日后能继续生长。","auditResult":2,"auditAnnotations":[]},{"versionId":"0","auditTime":1616981591,"auditorId":220012,"auditUser":{"uid":220012,"name":"思明","pic":"https://cache.soso.com/qlogo/g?b=oidb&k=cquZ3H4l5tJt7m8ZWXibvpg&s=100&t=1557929484","introduction":"","educations":null,"jobs":null,"works":null,"educationBrief":"","jobBrief":"","role":0,"roleName":null,"title":"","professionalTitle":"","phoneNo":null,"editable":true,"partnerId":201,"partnerIdCreateTime":1595845027,"partnerIdPoped":true},"auditReason":null,"auditSuggest":"根据评审员建议给予通过","auditResult":2,"auditAnnotations":[]}]},"isHistory":false};</script><script crossorigin="anonymous" src="//hhy.sogoucdn.com/aegis-sdk/latest/aegis.min.js"></script><script crossorigin="anonymous" src="//hhy.sogoucdn.com/js/common/polyfill/main_2020092401.js"></script><script crossorigin="anonymous" src="//hhy.sogoucdn.com/js/lib/react/17.0.2/react.production.min.js"></script><script crossorigin="anonymous" src="//hhy.sogoucdn.com/js/lib/react/17.0.2/react-dom.production.min.js"></script><script crossorigin="anonymous" src="//hhy.sogoucdn.com/js/lib/jquery/jquery-1.11.1.min.js"></script><script crossorigin="anonymous" src="//hhy.sogoucdn.com/js/common/hhy/main_2022062701.js"></script><script crossorigin="anonymous" src="//hhy.sogoucdn.com/js/deploy/new_baike/pc/general/main_66bbe21.js"></script><script crossorigin="anonymous" src="//hhy.sogoucdn.com/js/lib/react/17.0.2/react.production.min.js"></script><script crossorigin="anonymous" src="//hhy.sogoucdn.com/js/lib/react/17.0.2/react-dom.production.min.js"></script><script crossorigin="anonymous" src="//hhy.sogoucdn.com/js/deploy/new_baike/pc/detail/main_edf0f08.js"></script><div id="popControl"></div></body></html>